PDCD1 and amyotrophic lateral sclerosis: In ALS patients, inhibitory co-receptors like CTLA4 (cytotoxic T lymphocyte-associated protein 4) and PD-1 (programmed cell death protein-1) decrease, while stimulatory co-receptors like OX40 and GITR increase.